(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and Cardiomegaly

(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide has been researched along with Cardiomegaly in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alfulaij, N; Horton, JS; Kurokawa, T; Mori, Y; Shiraishi, T; Small-Howard, AL; Stokes, AJ; Turner, HC	1

Other Studies

1 other study(ies) available for (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and Cardiomegaly

Article	Year
"TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure". Channels (Austin, Tex.), 2019, Volume: 13, Issue:1 Topics: Acrylamides; Administration, Oral; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cardiomegaly; Heart Failure; HEK293 Cells; Humans; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Signal Transduction; Sildenafil Citrate; TRPV Cation Channels	2019

Article

Year

"TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure".

Channels (Austin, Tex.), 2019, Volume: 13, Issue:1

Topics: Acrylamides; Administration, Oral; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cardiomegaly; Heart Failure; HEK293 Cells; Humans; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Signal Transduction; Sildenafil Citrate; TRPV Cation Channels

2019